Proteomic analysis of traumatic brain injury: the search for biomarkers

References

• Ottens AK, Kobeissy FH, Golden EC et al. Neuroproteomics in neurotrauma. Mass Spectrom. Rev.25, 380–408 (2006).
   PubMed Web of Science ®Google Scholar
• Wang KKW, Ottens AK, Liu MC et al. Proteomic identification of biomarkers of traumatic brain injury. Expert Rev. Proteomics2(4), 603–614 (2005).
   PubMed Web of Science ®Google Scholar
• Okie S. Traumatic brain injury in the war zone. New Engl. J. Med.352(20), 2043–2057 (2005).
   PubMed Web of Science ®Google Scholar
• Keith RA, Granger CV, Hamilton BB et al. The functional independence measure: a new tool for rehabilitation. Adv. Clin. Rehabil.1, 6–18 (1987).
   PubMedGoogle Scholar
• Malkmus D, Booth BJ, Kodimer C. Rehabilitation of Head Injured Adults: Comprehensive Management. Downey (Ed.). Professional Staff Association of Ranchos Los Amigos Hospital, CA, USA (1980).
   Google Scholar
• Crooks CY, Zumsteg JM, Bell KR. Traumatic brain injury: a review of practice management and recent advances. Phys. Med. Rehabil. Clin. N. Am.18, 681–710 (2007).
   PubMedGoogle Scholar
• Mitchener A, Wyper DJ, Patterson J et al. SPECT, CT, and MRI in head injury: acute abnormalities followed up at six months. J. Neurol. Neurosurg. Psychiatr.62(6), 633–636 (1997).
   PubMed Web of Science ®Google Scholar
• Kant R, Smith-Seemiller L, Isaac G, Duffy J. Tc-HMPAO SPECT in persistent post-concussion syndrome after mild head injury: comparison with MRI/CT. Brain Inj.11(2), 115–124 (1997).
   PubMed Web of Science ®Google Scholar
• Jacobs A, Put E, Ingels M, Put T, Bossuyt A. One-year follow-up of technetium-99m-HMPAO SPECT in mild head injury. J. Nucl. Med.37(10), 1605–1609 (1996).
   PubMed Web of Science ®Google Scholar
• Collier V. Shopping Hospitals’ Price Lists. San Francisco Chronicles, CA, USA, E1 (2005).
   Google Scholar
• Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J. Head Trauma Rehabil.21(4), 315–333 (2006).
   PubMed Web of Science ®Google Scholar
• Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj.20(7), 759–765 (2006).
   PubMed Web of Science ®Google Scholar
• Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma24(12), 1793–1801 (2007).
   PubMed Web of Science ®Google Scholar
• Ottens AK, Golden EC, Bustamante L, Hayes RL, Denslow ND, Wang KK. Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry. J. Neurochem.104(5), 1404–1414 (2007).
   PubMedGoogle Scholar
• Onyszchuk G, Al-Hafez B, He YY et al. A mouse model of sensorimotor controlled cortical impact: characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology. J. Neurosci. Methods160(2), 187–196 (2007).
   PubMed Web of Science ®Google Scholar
• Brody DL, MacDonald C, Kessens CC et al. Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury. J. Neurotrama24(4), 657–673 (2007).
   PubMed Web of Science ®Google Scholar
• Yuan X, Desiderio DM. Proteomics analysis of human cerebrospinal fluid. J. Chromatogr.B Analyt. Technol. Biomed. Life Sci.815, 179–189 (2005).
   PubMed Web of Science ®Google Scholar
• Lehmensiek V, Sussmuth SD, Tauscher G et al. Cerebrospinal fluid proteome profile in multiple sclerosis. Mult. Scler.13(7), 840–849 (2007).
   PubMed Web of Science ®Google Scholar
• Conti A, Sanchez-Ruiz Y, Bachi A et al. Proteome study of human cerebrospinal fluid following traumatic brain injury indicate fibrin(ogen) degradation products as trauma-associated markers. J. Neurotrauma21, 854–863 (2004).
   PubMed Web of Science ®Google Scholar
• Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery45, 477–483 (1999).
   PubMed Web of Science ®Google Scholar
• Romner B. Traumatic brain damage: Serum S-100B protein measurements related to neuroradiological findings. J. Neurotrauma17, 641–647 (2000).
   PubMed Web of Science ®Google Scholar
• Zougman A, Pilch B, Podtelejnikov A et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J. Proteome Res.7(1), 386–399 (2008).
   PubMed Web of Science ®Google Scholar
• Ottens AK, Kobeissy FH, Fuller BF et al. Novel neuroproteomic approaches to studying traumatic brain injury. Prog. Brain Res.161, 401–418 (2007).
   PubMed Web of Science ®Google Scholar
• Kobeissy FH, Ottens AK, Zhang Z et al. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol. Cell. Proteomics5, 1887–1898 (2006).
   PubMed Web of Science ®Google Scholar
• Sironi L, Tremoli E, Miller I et al. Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics. Stroke32, 753–760 (2001).
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke32, 917–924 (2001).
   PubMed Web of Science ®Google Scholar
• Liu HM, Sturner WQ. Extravasation of plasma proteins in brain trauma. Forensic Sci. Int.38, 285–295 (1988).
   PubMedGoogle Scholar
• de las Heras R, Depaz I, Jaquet V, Kroon P, Wilce PA. Neuronal proteína 22 colocalizes with both the microtubule and microfilament cystoskeleton in neurite-like processes. Brain Res.1128(1), 12–20 (2007).
   PubMedGoogle Scholar
• Fan L. Jaquet V. Dodd PR, Chen W, Wilce PA. Molecular cloning and characterization of hNP22: a gene up-regulated in human alcoholic brain. J. Neurochem.76, 1275–1281 (2001).
   PubMedGoogle Scholar
• Blow N. Mass spectrometry: playing catch up. Nat. Methods4(12), 1059–1063 (2007).
   Google Scholar
• Robertson CL. Mitochondrial dysfunction contributes to cell death following traumatic brain injury in adult and immature animals. J. Bioenerg. Biomembr.36(4), 363–368 (2004).
   PubMed Web of Science ®Google Scholar
• Opii WO, Nukala VN, Sultana R et al. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J. Neurotrauma24(5), 772–789 (2007).
   PubMedGoogle Scholar
• Gao WM, Chadha MS, Berger RP et al. A gel-based comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. J. Neurotrauma24(1), 43–53 (2007).
   PubMed Web of Science ®Google Scholar
• Conti A, Sanchez-Ruiz Y, Bachi A et al. Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers. J. Neurotrauma21(7) 854–863 (2004).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics1(11) 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Issaq HJ, Xiao Z, Veenstra TD. Serum and plasma proteomics. Chem. Rev.107(8), 3601–3620 (2007).
   PubMed Web of Science ®Google Scholar
• Desrosiers RR, Beaulieu E, Buchanan M, Beliveau R. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high abundance proteins. Cell Biochem. Biophys.49(3), 182–195 (2007).
   PubMed Web of Science ®Google Scholar
• Aresta A, Calvano CD, Palmisano F et al. Imact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry. J. Pharm. Biomed. Anal.46, 157–164 (2008).
   PubMedGoogle Scholar
• Haqqani AS, Hutchison JS, Ward R et al. Protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. J. Neurotrauma24(1), 54–74 (2007).
   PubMedGoogle Scholar